A review of commercial developments and recent laboratory research of dialyzers and membranes for hemodialysis application

N Said, WJ Lau, YC Ho, SK Lim, MN Zainol Abidin… - Membranes, 2021 - mdpi.com
Dialyzers have been commercially used for hemodialysis application since the 1950s, but
progress in improving their efficiencies has never stopped over the decades. This article …

Renal rehabilitation: exercise intervention and nutritional support in dialysis patients

J Hoshino - Nutrients, 2021 - mdpi.com
With the growing number of dialysis patients with frailty, the concept of renal rehabilitation,
including exercise intervention and nutrition programs for patients with chronic kidney …

SGLT2 inhibitors in the treatment of diabetic kidney disease: more than just glucose regulation

J Klen, V Dolžan - Pharmaceutics, 2023 - mdpi.com
Diabetic kidney disease (DKD) is a severe and common complication and affects a quarter
of patients with type 2 diabetes mellitus (T2DM). Oxidative stress and inflammation related to …

Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study

M Sato, M Inaba, S Yamada, M Emoto, Y Ohno… - Journal of bone and …, 2021 - Springer
Introduction Romosozumab reportedly increases bone mineral density (BMD) potently but
might adversely affect cardiovascular disease (CVD). We evaluated the efficacy of …

Importance of considering malnutrition and sarcopenia in order to improve the QOL of elderly hemodialysis patients in Japan in the era of 100-year life

M Inaba, S Okuno, Y Ohno - Nutrients, 2021 - mdpi.com
In the current aging society of Japan, malnutrition and resultant sarcopenia have been
widely identified as important symptomatic indicators of ill health and can cause impairments …

Chronic kidney disease, gut dysbiosis, and constipation: a burdensome triplet

R Ikee, N Sasaki, T Yasuda, S Fukazawa - Microorganisms, 2020 - mdpi.com
Gut dysbiosis has been implicated in the progression of chronic kidney disease (CKD).
Alterations in the gut environment induced by uremic toxins, the dietary restriction of fiber …

Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study

JA Huijben, A Kramer, J Kerschbaum… - Nephrology Dialysis …, 2023 - academic.oup.com
Background The aim of this study was to describe the trends in the incidence, prevalence
and survival of patients on kidney replacement therapy (KRT) for end-stage kidney disease …

Surface engineering of a bioartificial membrane for its application in bioengineering devices

P Ray, R Chakraborty, O Banik, E Banoth, P Kumar - ACS omega, 2023 - ACS Publications
Membrane technology is playing a crucial role in cutting-edge innovations in the biomedical
field. One such innovation is the surface engineering of a membrane for enhanced longevity …

Sodium-glucose cotransporter-2 inhibitors—miracle drugs for the treatment of chronic Kidney disease irrespective of the diabetes status: Lessons from the dedicated …

T Gohda, M Murakoshi - International Journal of Molecular Sciences, 2022 - mdpi.com
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease (CKD) and
end-stage kidney disease worldwide. In Japan, the proportion of new patients requiring …

Pleiotropic effects of sodium-glucose cotransporter-2 inhibitors: renoprotective mechanisms beyond glycemic control

T Takata, H Isomoto - International Journal of Molecular Sciences, 2021 - mdpi.com
Diabetes mellitus is a major cause of chronic kidney disease and end-stage renal disease.
However, the management of chronic kidney disease, particularly diabetes, requires vast …